Cordycepin
I. Source and Physicochemical Properties of Cordycepin
![]()
(1) Source
Cordycepin, chemically known as 3′-deoxyadenosine, is a natural purine nucleotide derivative and is hailed as a natural antibiotic. It is primarily enriched in Cordyceps militaris, with small amounts found in other Cordyceps fungi such as Cordyceps kyushuensis. Additionally, microorganisms like Acremonium terricola also possess the ability to synthesize cordycepin, and their fermentation products serve as core raw materials for green feed additives. Due to the scarcity of wild Cordyceps resources and overharvesting leading to resource depletion, liquid-state deep fermentation of Cordyceps militaris and microbial heterologous synthesis have become the mainstream methods for large-scale cordycepin production, replacing traditional wild harvesting.
(ii) Physical and Chemical Properties
1. Basic structure: Molecular formula C10H13N5O3, relative molecular mass 251.25, highly similar in structure to adenosine, except that the 3′ position of the ribose five-carbon ring lacks one oxygen atom.
2. Appearance: White to beige granular crystals.
3. Physical parameters: Melting point 225~229°C, boiling point 394.4°C, specific optical rotation D20 -47°; UV characteristic absorption wavelength 260nm.
4. Solubility: Easily soluble in water, ethanol, methanol, and DMSO; insoluble in benzene, ether, and chloroform; the aqueous solution is neutral.
5. Stability and Storage: Chemically stable, store sealed away from light under normal conditions; for long-term storage, a low-temperature environment of -20°C is required.
II. Biological Effects and Mechanism of Action of Cordycepin
Cordycepin possesses four core biological activities: anti-inflammatory, antibacterial and antiviral, antioxidant, and immunomodulatory. It has no drug residues, no drug resistance, and no toxic side effects, making it suitable for multiple application scenarios including medicine, feed, cosmetics, and functional foods.
(I) Anti-inflammatory effects and mechanisms
1. Downregulation of inflammatory mediators: Inhibits the expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), reduces the production of inflammatory mediators such as NO and PGE2, and decreases the secretion of pro-inflammatory cytokines including IL-1β, IL-6, and TNF-α.
2. Regulation of signaling pathways: Targeting the TLR4/NF-κB pathway to inhibit IκB-α phosphorylation and block NF-κB nuclear activation; simultaneously suppressing NLRP3 inflammasome and pyroptosis-related proteins Caspase-1 and GSDMD expression, thereby alleviating acute and chronic inflammation and tissue damage.
(ii) Antibacterial and antiviral effects and mechanisms
1. Antibacterial: It exhibits selective bacteriostatic effects, with significant inhibition against Gram-positive bacteria (Staphylococcus aureus) and weaker effects against some Gram-negative bacteria. By disrupting the integrity of the bacterial cell wall and membrane, it causes leakage of intracellular nucleic acids and enzymes, interferes with peptidoglycan synthesis, and leads to bacterial lysis and death.
2. Antiviral: By leveraging structural similarity to adenosine, it inhibits the viral RNA-dependent RNA polymerase (RdRp), blocking viral RNA replication. It can bind to the RBD domain of the coronavirus S protein and the main protease (Mpro), altering the conformation of viral proteins and preventing the virus from invading host cells. It shows inhibitory potential against dengue, COVID-19, and porcine reproductive and respiratory syndrome virus (PRRSV).
(III) Antioxidant Effect and Mechanism
1. Activation of the Keap1/Nrf2 signaling pathway: Promotes Nrf2 nuclear translocation, upregulates the expression of antioxidant genes such as HO-1 and NQO1, and enhances the body’s endogenous antioxidant defense.
2. Enhance antioxidant levels: Increase the activity of antioxidant enzymes such as SOD, CAT, and GSH-Px, raise the levels of non-enzymatic antioxidants like vitamin C and vitamin E, reduce the oxidative damage marker MDA, eliminate excess ROS, alleviate oxidative stress, and protect organ and germ cell function.
(IV) Efficacy Specific to Livestock and Poultry Applications
In livestock and poultry farming, it can improve the structure of intestinal microbiota, enhance feed conversion rate, reduce the incidence of diarrhea in piglets, and boost immunity; it can also improve the quality of boar sperm, enhance the egg-laying performance and egg quality of poultry, optimize the rumen fermentation function of dairy cows, and increase milk production.
IV. Cordycepin Market Analysis
(I) Market Size and Growth Rate
According to Global Info Research data, the global Cordyceps extract market size was approximately USD 79.8 million in 2024, and is expected to reach USD 169 million by 2031, with a compound annual growth rate (CAGR) of 11.4% from 2025 to 2031.
2. As a core high-activity monomer, cordycepin can reach a maximum price of $480,000/kg at the high-end reagent grade, while prices for food-grade and feed-grade cordycepin continue to decline with the iteration of biosynthesis technologies, indicating significant potential for market expansion.
(II) Distribution of Application Fields
1. Pharmaceutical field: The largest proportion, used in chronic bronchitis, renal insufficiency, tumor adjuvant therapy, and anti-inflammatory and antiviral drug development; fermented cordycepin fungal powder preparations (Bailing Capsules, Jinshuibao Capsules) have been approved for market.
2. Functional Foods and Dietary Supplements: This is currently the largest track, focusing on immune regulation, anti-fatigue, antioxidant, and anti-aging effects. Dietary supplement products in Europe, the United States, and China continue to see volume growth, while derivative categories such as functional teas and protein bars are rapidly emerging.
3. Cosmetics Field: With its antioxidant, anti-wrinkle soothing, and collagen synthesis-promoting effects, it has become a popular choice for medical aesthetic repair and anti-aging ingredients, with market penetration increasing year by year.
4. Livestock and Poultry Feed Additives: Replace traditional antibiotics, with no residues and no drug resistance. Suitable for pig, poultry, and ruminant farming, supporting the implementation of policies to reduce and limit antibiotic use in the breeding industry, with rigid demand growth.
5. Emerging Fields: With potential as a bioherbicide that can inhibit plant photosynthesis and growth, it is expected to open up new markets in the field of agricultural plant protection.
(III) Competitive Landscape and Current Supply Situation
1. The global market landscape is fragmented, with domestic enterprises primarily focusing on raw material supply, represented by companies such as Dalian Lanshi Biotechnology and Henan Huazhong Biotechnology. International brands concentrate on finished end-products, while domestic players are gradually shifting from raw material OEM to high-value-added end products.
2. Supply-side bottlenecks: Traditional processes suffer from low yields and high costs; synthetic biology-based heterologous synthesis technology has become the core of industry competition. Leading companies are deploying engineering modifications of yeast and mold strains to seize the benefits of low-cost production capacity.
(IV) Industry Pain Points and Development Trends
1. Existing Pain Points
Limited production of natural cordycepin, high prices for high-purity monomers; lack of systematic standards for application dosages and effects across different livestock and poultry species; and unexplored areas in the mechanism of action that still require in-depth investigation.
2. Development Trends
Production side: Synthetic biology technology continues to iterate, with microbial heterologous synthesis gradually replacing traditional extraction and chemical synthesis, achieving cost reduction, quality improvement, and greener processes.
Application side: The demand in the feed additive track has exploded, high-end products in the pharmaceutical and beauty sectors continue to expand, and multi-scenario application standards are gradually improving.
Product Selection End: High-purity biosynthetic cordycepin (food grade, feed grade, pharmaceutical grade) holds long-term investment value and is well-suited for the three golden tracks of the health industry, animal husbandry, and medical aesthetics.
(V) Summary of Investment Value in Product Selection
Cordycepin has clear biological activity and a wide range of applications, aligning perfectly with the three major industry trends: reduced antibiotic farming, healthy consumption, and natural cosmetics. With breakthroughs in microbial synthesis technology, its cost has significantly decreased, leaving ample room for market penetration. Its residue-free and high-safety characteristics give it long-term scarcity, making it a high-quality target in the field of biosynthesis.
Leave a Reply
Your email is safe with us.